The all-virtual program is currently looking for a second cohort of novel diagnostics technologies, with a Sept. 30 deadline for new applications.

According to a company executive, the transactions will provide QuidelOrtho with greater financial flexibility while funding its continued growth.

NEW YORK — The Scottish government has earmarked £800,000 ($1.1 million) to support the introduction of a Genedrive test to help prevent antibiotic-induced deafness in newborns within the country, ...

Reviewers winnowed an initial 27 assays to a group of nine that were evaluated using NCI sample sets, ultimately choosing ClearNote's Avantect and Guardant's Shield.

The organization noted that US senators have introduced a bill to accelerate Medicare coverage for breakthrough devices.

UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other diseases through a droplet-size saliva sample.

The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage ...

Ospri specializes in PCR-based infectious disease detection and is financed by up to $30 million of strategic funding from Catalio Capital Management.

NEW YORK – BioMérieux announced Monday that it has obtained an expanded claim from the US Food and Drug Administration as well as CLIA waiver for its Respiratory/Sore Throat (R/ST) Panel Mini SpotFire ...

NEW YORK – Lumos Diagnostics announced Monday that it has completed a clinical trial of its FebriDx test and submitted it to the US Food and Drug Administration for CLIA waiver. If granted, the waiver ...

Last week, readers were most interested in a story about WHO's update to its operational handbook for diagnosing tuberculosis.